Pulse Biosciences, Inc.
PLSE
$17.74
$0.855.03%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 118.04M | 79.03M | 26.20M | 34.89M | 44.37M |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 1.41M | 1.38M | 1.04M | 964.00K | 963.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 119.45M | 80.41M | 27.24M | 35.85M | 45.33M |
|
|||||
Total Current Assets | 119.45M | 80.41M | 27.24M | 35.85M | 45.33M |
Net Property, Plant & Equipment | 8.32M | 7.81M | 8.13M | 8.44M | 8.78M |
Long-term Investments | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M |
Goodwill | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M |
Total Other Intangibles | 1.22M | 1.39M | 1.55M | 1.72M | 1.89M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 677.00K | 646.00K | 714.00K | 365.00K | 365.00K |
Total Assets | 132.46M | 93.05M | 40.43M | 49.16M | 59.15M |
|
|||||
Total Accounts Payable | 1.67M | 1.73M | 1.64M | 1.71M | 1.84M |
Total Accrued Expenses | 5.83M | 3.82M | 3.18M | 2.27M | 3.81M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 1.36M | 1.19M | 1.15M | 1.10M | 1.06M |
Total Finance Division Other Current Liabilities | 1.20M | -- | -- | -- | -- |
Total Other Current Liabilities | 1.20M | -- | -- | -- | -- |
Total Current Liabilities | 10.06M | 6.74M | 5.96M | 5.08M | 6.71M |
|
|||||
Total Current Liabilities | 10.06M | 6.74M | 5.96M | 5.08M | 6.71M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 7.54M | 7.17M | 7.50M | 7.80M | 8.09M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 17.60M | 13.92M | 13.46M | 12.88M | 14.79M |
|
|||||
Common Stock & APIC | 505.36M | 450.25M | 385.40M | 383.34M | 381.28M |
Retained Earnings | -390.50M | -371.12M | -358.44M | -347.05M | -336.92M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 114.86M | 79.13M | 26.97M | 36.29M | 44.36M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 114.86M | 79.13M | 26.97M | 36.29M | 44.36M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 114.86M | 79.13M | 26.97M | 36.29M | 44.36M |
|